Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
VNUS MEDICAL TECHNOLOGIES INC (VNUS)
|
Add to portfolio |
|
|
|
| Price: |
$28.76
| | Metrics |
| OS: |
16.2
|
M
| |
2
|
% ROE
|
| Market cap: |
$467
|
M
| |
25
|
% ROIC
|
|
Net cash:
|
$86.4
|
M
| |
$5.32
|
per share
|
|
EV:
|
$380
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$18.2
|
M
| |
20.9
|
x EV/EBITDA
|
|
EBIT
|
$16.6
|
M
| |
22.9
|
x EV/EBIT
|
| EPS |
($69.87)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 |
| Revenues | 101.2 | 70.9 | 51.7 | 49.2 | 38.2 | 21.8 | 10.0 |
| Revenue growth | 42.7% | 37.2% | 5.1% | 28.8% | 74.8% | 117.5% | |
| Cost of goods sold | 29.3 | 25.7 | 17.3 | 12.3 | 9.5 | 6.3 | 3.6 |
| Gross profit | 71.8 | 45.2 | 34.4 | 36.9 | 28.6 | 15.5 | 6.4 |
| Gross margin | 71.0% | 63.7% | 66.6% | 75.0% | 75.0% | 71.1% | 63.7% |
| Sales and marketing | 28.4 | 25.3 | 22.3 | 20.2 | 16.2 | 12.0 | 7.7 |
| Research and development | 10.4 | 9.4 | 7.4 | 3.8 | 4.5 | 3.5 | 2.2 |
| General and administrative | 19.7 | 19.3 | 15.4 | 9.0 | 5.2 | 2.8 | 2.7 |
| EBIT | 13.3 | -8.9 | -10.8 | 3.8 | 2.6 | -2.8 | -6.2 |
| EBIT margin | 13.2% | -12.5% | -20.8% | 7.8% | 6.9% | -12.6% | -62.1% |
| Pre-tax income | 14.6 | -5.4 | -7.3 | 5.6 | 3.1 | -2.6 | -6.0 |
| Income taxes | 1.1 | 0.1 | 0.0 | 0.3 | 0.2 | 0.0 | 0.0 |
| Tax rate | 7.3% | | | 4.9% | 7.2% | 0.0% | 0.0% |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.6 | -6.0 |
| Net margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -11.8% | -59.3% |
| |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ($1,974.03) | ($4,726.19) |
| Shares outstanding (diluted) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|